[HTML][HTML] The signaling pathways and targets of natural compounds from traditional Chinese medicine in treating ischemic stroke
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun, GL Yan… - Molecules, 2022 - mdpi.com
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
[HTML][HTML] The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun, GL Yan… - Molecules, 2022 - ncbi.nlm.nih.gov
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The signaling pathways and targets of natural compounds from traditional Chinese medicine in treating ischemic stroke.
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun, GL Yan… - 2022 - cabidigitallibrary.org
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun… - Molecules (Basel …, 2022 - europepmc.org
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke
XH Li, FT Yin, XH Zhou, AH Zhang… - Molecules (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke
L Xing-Hua, Y Feng-Ting, Z Xiao-Hang, Z Ai-Hua… - …, 2022 - search.proquest.com
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun… - …, 2022 - search.ebscohost.com
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
The Signaling Pathways and Targets of Natural Compounds from Traditional Chinese Medicine in Treating Ischemic Stroke.
XH Li, FT Yin, XH Zhou, AH Zhang, H Sun… - Molecules (Basel …, 2022 - europepmc.org
Ischemic stroke (IS) is a common neurological disorder associated with high disability rates
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …
and mortality rates. At present, recombinant tissue plasminogen activator (r-tPA) is the only …